P.-M. Roger

1.2k total citations
32 papers, 563 citations indexed

About

P.-M. Roger is a scholar working on Infectious Diseases, Organic Chemistry and Molecular Biology. According to data from OpenAlex, P.-M. Roger has authored 32 papers receiving a total of 563 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 8 papers in Organic Chemistry and 6 papers in Molecular Biology. Recurrent topics in P.-M. Roger's work include Carbohydrate Chemistry and Synthesis (7 papers), Antibiotic Use and Resistance (4 papers) and HIV/AIDS drug development and treatment (3 papers). P.-M. Roger is often cited by papers focused on Carbohydrate Chemistry and Synthesis (7 papers), Antibiotic Use and Resistance (4 papers) and HIV/AIDS drug development and treatment (3 papers). P.-M. Roger collaborates with scholars based in France, Belgium and United States. P.-M. Roger's co-authors include Michel Geslin, Guy Griebel, M. Jung, Danielle Gully, Jacques Simiand, R. Steinberg, Jean‐Pierre Maffrand, B. Scatton, Philippe Soubrié and P. Dellamonica and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and Journal of Antimicrobial Chemotherapy.

In The Last Decade

P.-M. Roger

31 papers receiving 546 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P.-M. Roger France 11 163 132 88 86 83 32 563
Jennifer R. Baker Australia 19 39 0.2× 257 1.9× 68 0.8× 9 0.1× 93 1.1× 48 1.1k
Francis Gengo United States 14 43 0.3× 55 0.4× 19 0.2× 8 0.1× 6 0.1× 36 659
Fatemah O. Kamel Saudi Arabia 10 18 0.1× 114 0.9× 10 0.1× 30 0.3× 7 0.1× 36 633
Benito J. Cerimele United States 14 17 0.1× 135 1.0× 17 0.2× 43 0.5× 28 0.3× 33 953
Nobuhiro Nishimura Japan 12 20 0.1× 164 1.2× 10 0.1× 10 0.1× 8 0.1× 38 762
Peter S. Mueller United States 16 52 0.3× 173 1.3× 16 0.2× 43 0.5× 50 0.6× 34 1.0k
Silvia Novío Spain 14 38 0.2× 91 0.7× 6 0.1× 39 0.5× 30 0.4× 29 393
James M. Stevenson United States 16 9 0.1× 147 1.1× 10 0.1× 45 0.5× 50 0.6× 52 1.0k
Vandana Tayal India 10 25 0.2× 83 0.6× 17 0.2× 15 0.2× 8 0.1× 17 524
A. Fiorentini Italy 14 33 0.2× 66 0.5× 43 0.5× 106 1.2× 9 0.1× 31 841

Countries citing papers authored by P.-M. Roger

Since Specialization
Citations

This map shows the geographic impact of P.-M. Roger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.-M. Roger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.-M. Roger more than expected).

Fields of papers citing papers by P.-M. Roger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P.-M. Roger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.-M. Roger. The network helps show where P.-M. Roger may publish in the future.

Co-authorship network of co-authors of P.-M. Roger

This figure shows the co-authorship network connecting the top 25 collaborators of P.-M. Roger. A scholar is included among the top collaborators of P.-M. Roger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P.-M. Roger. P.-M. Roger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Allavena, Clotilde, Christine Katlama, Laurent Cotte, et al.. (2016). Long-term efficacy and safety of etravirine-containing regimens in a real-life cohort of treatment-experienced HIV-1-infected patients. Infectious Diseases. 48(5). 392–398. 5 indexed citations
2.
Risso, Karine, Gaurav Kumar, Michel Ticchioni, et al.. (2015). Early infectious acute respiratory distress syndrome is characterized by activation and proliferation of alveolar T-cells. European Journal of Clinical Microbiology & Infectious Diseases. 34(6). 1111–1118. 34 indexed citations
3.
Pulcini, C., Lilia Hasseine, V. Mondain, G. Baudin, & P.-M. Roger. (2012). Possible pandemic HIN1 influenza complicated by Pneumocystis jirovecii pneumonia in an HIV-infected patient. Journal de Mycologie Médicale. 22(1). 88–91. 5 indexed citations
4.
5.
Hasseine, Lilia, et al.. (2011). Invasive periodic multivisceral aspergillosis in HIV-infected patient with normal CD4+ cell count. Journal de Mycologie Médicale. 21(2). 146–151. 1 indexed citations
6.
Roger, P.-M., et al.. (2009). T-08 Réévaluation de l’antibiothérapie à 48-72 heures (R-ATB) à l’échelle d’un Centre Hospitalier Régional. Médecine et Maladies Infectieuses. 39. S16–S16. 1 indexed citations
7.
Roger, P.-M., et al.. (2008). Gestion de services, tarification à l’activité, recherche clinique et évaluation des pratiques professionnelles : un même outil informatique. Médecine et Maladies Infectieuses. 38(9). 457–464. 15 indexed citations
8.
Pulcini, C., Éric Cua, F. Lieutier, et al.. (2007). Antibiotic misuse: a prospective clinical audit in a French university hospital. European Journal of Clinical Microbiology & Infectious Diseases. 26(4). 277–280. 73 indexed citations
9.
Galimand, Marc, F. Vandenbos, Christian Pradier, et al.. (2005). In vitro selection of mutants of Streptococcus pneumoniae resistant to macrolides and linezolid: relationship with susceptibility to penicillin G or macrolides. Journal of Antimicrobial Chemotherapy. 56(4). 633–642. 10 indexed citations
10.
Roger, P.-M.. (2003). Apoptosis and proliferation kinetics of T cells in patients having experienced antiretroviral treatment interruptions. Journal of Antimicrobial Chemotherapy. 52(2). 269–275. 2 indexed citations
11.
12.
Fontaine, Evelyne, et al.. (2001). Synthesis of optically-active benzylic amines; asymmetric reduction of ketoxime ethers with chiral oxazaborolidines. Tetrahedron Asymmetry. 12(15). 2185–2189. 34 indexed citations
13.
Dellamonica, P., et al.. (2001). How to organise antibiotic prescription. International Journal of Antimicrobial Agents. 18(3). 299–303. 5 indexed citations
14.
Roger, P.-M., et al.. (1997). Synthesis of 6-Hydroxy-L-Daunosamine and L-Daunosamine Derivatives. Journal of Carbohydrate Chemistry. 16(1). 25–48. 12 indexed citations
15.
Monneret, Claude, et al.. (1991). Synthesis of 3′-azido-5′-homothymidine analogs. Tetrahedron Letters. 32(28). 3361–3364. 7 indexed citations
16.
Roger, P.-M., et al.. (1991). Chemical stability of ecomustine, a new antitumor agent in aqueous and biological media as assessed by high-performance liquid chromatography. Cancer Chemotherapy and Pharmacology. 27(4). 295–300. 1 indexed citations
17.
Gouyette, Alain, et al.. (1990). Synthese du methyl [(chloro‐2 ethyl)‐3 nitroso‐3 ureido]‐3 didesoxy‐2, 3 α‐D‐arabino‐hexopyrannoside marque AU carbone‐14 OU −AU carbone‐13 (CY 233 ‐ SR 90098). Journal of Labelled Compounds and Radiopharmaceuticals. 28(6). 653–665. 2 indexed citations
18.
Martı́n, Antonio, Claude Monneret, Cécile Gautier, Jean Fournier, & P.-M. Roger. (1990). Synthesis of Methyl 3-Amino-3,4-Dideoxy-α and ß-D-Xylo-Hexopyranosides. Journal of Carbohydrate Chemistry. 9(6). 853–861. 1 indexed citations
19.
Gosse, Charlie, Ghanem Atassi, Yves Letourneux, et al.. (1989). Antitumour activity of a new water-soluble nitrosoureido sugar: CY233 (NSC 609224).. PubMed. 8(6). 1419–22. 3 indexed citations
20.
Atassi, Ghanem, Patrick Dumont, Charlie Gosse, et al.. (1989). Characterization of the anti-tumour activity against solid tumours of a new nitrosoureido sugar: Cy 233. Cancer Chemotherapy and Pharmacology. 25(3). 205–209. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jennifer R. Baker Breakdown of academic impact, for papers by Francis Gengo Breakdown of academic impact, for papers by Fatemah O. Kamel Breakdown of academic impact, for papers by Benito J. Cerimele Breakdown of academic impact, for papers by Nobuhiro Nishimura Breakdown of academic impact, for papers by Peter S. Mueller Breakdown of academic impact, for papers by Silvia Novío Breakdown of academic impact, for papers by James M. Stevenson Breakdown of academic impact, for papers by Vandana Tayal Breakdown of academic impact, for papers by A. Fiorentini
Rankless by CCL
2026